By Keith Goldberg ( June 25, 2012, 2:54 PM EDT) -- The U.S. Food and Drug Administration has again delayed its decision on whether to approve a drug designed to reduce the risk of blood clots and prevent stroke and systemic embolism, Pfizer Inc. and Bristol-Myers Squibb Co. said Monday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.